Загрузка...
Pharmacological treatment of obsessive-compulsive disorder
Obsessive-compulsive disorder (OCD) affects up to 2.5% of the population of the course of a lifetime and produces substantial morbidity. Approximately 70% of patients can experience significant symptomatic relief with appropriate pharmacotherapy. The selective serotonin reuptake inhibitors (SSRIs) a...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4143776/ https://ncbi.nlm.nih.gov/pubmed/25150568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psc.2014.05.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|